Tratamento da retinite pelo virus citomegálico na infecção pelo vírus da imunodeficiência humana.

Most of the patients with immunodeficiency virus infection (75%-85%) are coinfected with cytomegalovirus. It is estimated that cytomegalovirus disease develops in 45% of them, mainly those presenting low CD4 cell counts (< 100/mm3). Retinitis is the most common manifestation of reactivated cytome...

Full description

Bibliographic Details
Main Authors: E Rabadão, V Duque, A Meliço-Silvestre
Format: Article
Language:English
Published: Ordem dos Médicos 1999-06-01
Series:Acta Médica Portuguesa
Online Access:https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2142
_version_ 1811242455903764480
author E Rabadão
V Duque
A Meliço-Silvestre
author_facet E Rabadão
V Duque
A Meliço-Silvestre
author_sort E Rabadão
collection DOAJ
description Most of the patients with immunodeficiency virus infection (75%-85%) are coinfected with cytomegalovirus. It is estimated that cytomegalovirus disease develops in 45% of them, mainly those presenting low CD4 cell counts (< 100/mm3). Retinitis is the most common manifestation of reactivated cytomegalovirus disease (85%), followed by other extra ocular sites (central nervous system, lungs, gastrointestinal system, adrenal glands, etc.). The particularly high incidence of cytomegalovirus retinitis, the difficulties concerning its therapeutical approach and the relatively unsatisfactory results, justify this review, according to the new treatment options presented in recent literature.
first_indexed 2024-04-12T13:51:32Z
format Article
id doaj.art-cddcd94729524c298a085fcec9204d63
institution Directory Open Access Journal
issn 0870-399X
1646-0758
language English
last_indexed 2024-04-12T13:51:32Z
publishDate 1999-06-01
publisher Ordem dos Médicos
record_format Article
series Acta Médica Portuguesa
spelling doaj.art-cddcd94729524c298a085fcec9204d632022-12-22T03:30:30ZengOrdem dos MédicosActa Médica Portuguesa0870-399X1646-07581999-06-01124-610.20344/amp.2142Tratamento da retinite pelo virus citomegálico na infecção pelo vírus da imunodeficiência humana.E Rabadão0V DuqueA Meliço-SilvestreDepartamento de Doenças Infecciosas, Hospitais da Universidade de Coimbra.Most of the patients with immunodeficiency virus infection (75%-85%) are coinfected with cytomegalovirus. It is estimated that cytomegalovirus disease develops in 45% of them, mainly those presenting low CD4 cell counts (< 100/mm3). Retinitis is the most common manifestation of reactivated cytomegalovirus disease (85%), followed by other extra ocular sites (central nervous system, lungs, gastrointestinal system, adrenal glands, etc.). The particularly high incidence of cytomegalovirus retinitis, the difficulties concerning its therapeutical approach and the relatively unsatisfactory results, justify this review, according to the new treatment options presented in recent literature.https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2142
spellingShingle E Rabadão
V Duque
A Meliço-Silvestre
Tratamento da retinite pelo virus citomegálico na infecção pelo vírus da imunodeficiência humana.
Acta Médica Portuguesa
title Tratamento da retinite pelo virus citomegálico na infecção pelo vírus da imunodeficiência humana.
title_full Tratamento da retinite pelo virus citomegálico na infecção pelo vírus da imunodeficiência humana.
title_fullStr Tratamento da retinite pelo virus citomegálico na infecção pelo vírus da imunodeficiência humana.
title_full_unstemmed Tratamento da retinite pelo virus citomegálico na infecção pelo vírus da imunodeficiência humana.
title_short Tratamento da retinite pelo virus citomegálico na infecção pelo vírus da imunodeficiência humana.
title_sort tratamento da retinite pelo virus citomegalico na infeccao pelo virus da imunodeficiencia humana
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2142
work_keys_str_mv AT erabadao tratamentodaretinitepeloviruscitomegaliconainfeccaopelovirusdaimunodeficienciahumana
AT vduque tratamentodaretinitepeloviruscitomegaliconainfeccaopelovirusdaimunodeficienciahumana
AT amelicosilvestre tratamentodaretinitepeloviruscitomegaliconainfeccaopelovirusdaimunodeficienciahumana